Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outcomes of TKA Under General vs Spinal Anesthesia
NCT03364088Completed
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection, propofol injection (veterinary) and remifentanil in knee osteoarthritis (OA), rheumatoid arthritis (RA) and knee arthropathy (4 arms). Primary endpoint: Opioid consumption. Started Oct 2016; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionpropofol injection (veterinary)remifentanil
03
Conditions
knee osteoarthritis (OA)rheumatoid arthritis (RA)knee arthropathy
Beyond the preview
Go deeper on NCT03364088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364088.